Cieślik, P.; Radulska, A.; Burnat, G.; Kalinowski, L.; Wierońska, J.M.
Serotonergic–Muscarinic Interaction within the Prefrontal Cortex as a Novel Target to Reverse Schizophrenia-Related Cognitive Symptoms. Int. J. Mol. Sci. 2021, 22, 8612.
https://doi.org/10.3390/ijms22168612
AMA Style
Cieślik P, Radulska A, Burnat G, Kalinowski L, Wierońska JM.
Serotonergic–Muscarinic Interaction within the Prefrontal Cortex as a Novel Target to Reverse Schizophrenia-Related Cognitive Symptoms. International Journal of Molecular Sciences. 2021; 22(16):8612.
https://doi.org/10.3390/ijms22168612
Chicago/Turabian Style
Cieślik, Paulina, Adrianna Radulska, Grzegorz Burnat, Leszek Kalinowski, and Joanna M. Wierońska.
2021. "Serotonergic–Muscarinic Interaction within the Prefrontal Cortex as a Novel Target to Reverse Schizophrenia-Related Cognitive Symptoms" International Journal of Molecular Sciences 22, no. 16: 8612.
https://doi.org/10.3390/ijms22168612
APA Style
Cieślik, P., Radulska, A., Burnat, G., Kalinowski, L., & Wierońska, J. M.
(2021). Serotonergic–Muscarinic Interaction within the Prefrontal Cortex as a Novel Target to Reverse Schizophrenia-Related Cognitive Symptoms. International Journal of Molecular Sciences, 22(16), 8612.
https://doi.org/10.3390/ijms22168612